| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309377 | Clinica Chimica Acta | 2018 | 7 Pages |
Abstract
In meta-analysis of studies which used gemcitabine-based therapies, higher RRM1 expression is found to associated with shorter OS but not PFS. HR depicting relationship between RRM1 expression and OS/PFS/treatment response could not demonstrate a prognostic role of RRM1 in NSCLC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Cui-min Zhu, Xiang-yao Lian, Ying-hui Bi, Chan-chan Hu, Yun-wei Liang, Qing-shan Li,